Tylenol w/ codeine no. 3 and Calcitriol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tylenol w/ codeine no. 3 (acetaminophen; codeine phosphate) and Calcitriol (calcitriol). Common drug interactions include vomiting among females and alanine aminotransferase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Tylenol w/ codeine no. 3 and Calcitriol. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Tylenol w/ codeine no. 3?

Tylenol w/ codeine no. 3 has active ingredients of acetaminophen; codeine phosphate. It is often used in pain. eHealthMe is studying from 4,920 Tylenol w/ codeine no. 3 users. Check the latest studies of Tylenol w/ codeine no. 3.

What is Calcitriol?

Calcitriol has active ingredients of calcitriol. It is often used in hypoparathyroidism. eHealthMe is studying from 24,162 Calcitriol users. Check the latest studies of Calcitriol.



On Jul, 20, 2026

18 people who take Tylenol w/ codeine no. 3 and Calcitriol together, and have interactions are studied.

Tylenol w/ codeine no. 3 and Calcitriol drug interactions.

What are the common drug interactions of Tylenol W/ Codeine No. 3 and Calcitriol, by gender? *:

female:

  1. Vomiting
  2. Drug ineffective
  3. Nausea (feeling of having an urge to vomit)
  4. Atelectasis (partial or complete collapse of the lung)
  5. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  6. Carotid artery stenosis (narrowing of carotid artery)
  7. Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
  8. Decreased appetite
  9. Dehydration (dryness resulting from the removal of water)
  10. Diarrhoea

male:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Blood glucose increased
  4. Hepatic enzyme increased
  5. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  6. Peritoneal dialysis complication
  7. Peritonitis bacterial (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs by bacterial)
  8. Pyrexia (fever)
  9. Respiratory disorder (respiratory disease)

What are the common drug interactions of Tylenol W/ Codeine No. 3 and Calcitriol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Peritoneal dialysis complication
  2. Peritonitis bacterial (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs by bacterial)
  3. Pyrexia (fever)

20-29:

n/a

30-39:

n/a

40-49:

  1. Acute myocardial infarction (acute heart attack)
  2. Renal failure acute (rapid kidney dysfunction)

50-59:

  1. Constipation
  2. Peritoneal dialysis complication
  3. Peritonitis bacterial (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs by bacterial)

60+:

  1. Red cell aplasia (a type of anaemia affecting the precursors to red blood cells)
  2. Vomiting
  3. Decreased appetite
  4. Dehydration (dryness resulting from the removal of water)
  5. Diarrhoea
  6. Failure to thrive (inadequate weight gain and physical growth in children)
  7. Hypoglycaemia (deficiency of glucose in the bloodstream)
  8. Hypokalaemia (low potassium)
  9. Mitral valve incompetence (inefficient heart valve)
  10. Ovarian neoplasm (tumour of ovary)

What are the existing conditions these people have? *

  1. Chronic Renal Failure (kidney failure): 2 people, 11.11%
  2. Cardiac Failure Congestive: 2 people, 11.11%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.56%
  4. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 5.56%
  5. Nuclear Magnetic Resonance Imaging Brain: 1 person, 5.56%
  6. Nuclear Magnetic Resonance Imaging Abdominal: 1 person, 5.56%
  7. High Blood Cholesterol: 1 person, 5.56%
  8. Diabetes: 1 person, 5.56%
  9. Back Pain: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Tylenol w/ codeine no. 3 and Calcitriol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tylenol w/ codeine no. 3 and Calcitriol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tylenol w/ codeine no. 3:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Calcitriol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tylenol w/ codeine no. 3 and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Calcitriol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; codeine phosphate and calcitriol (the active ingredients of Tylenol w/ codeine no. 3 and Calcitriol, respectively), and Tylenol w/ codeine no. 3 and Calcitriol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: